Which factors influence the different outcome of therapy in adults and children with ALL?

Blinatumomab vs historical standard therapy of adult relapsed/refractory acute lymphoblastic leukemia.

Blood cancer journal·2016

Detection of Minimal Residual Disease in Adult Acute Lymphoblastic Leukemia by Analysis of Gene Rearrangements and Correlation with Early Relapses.

Leukemia & lymphoma·2016

Change in prognostic factors.

Leukemia supplements·2016

PF-114, a potent and selective inhibitor of native and mutated BCR/ABL is active against Philadelphia chromosome-positive (Ph+) leukemias harboring the T315I mutation.

Leukemia·2014

Randomized comparison of prophylactic and minimal residual disease-triggered imatinib after allogeneic stem cell transplantation for BCR-ABL1-positive acute lymphoblastic leukemia.

Leukemia·2012

Clinical and molecular characterization of early T-cell precursor leukemia: a high-risk subgroup in adult T-ALL with a high frequency of FLT3 mutations.

Blood cancer journal·2012

How could calreticulin-targeting therapies change the myelofibrosis transplant paradigm?

Bone marrow transplantation·2026

The prognostic impact of CEBPA mutation in acute myeloid leukemia patients undergoing allogeneic hematopoietic stem cell transplantation.

Bone marrow transplantation·2026

Bridging therapy in pediatric and AYA patients under 25 years with relapsed/refractory B-ALL undergoing anti-CD19 CAR-T therapy: a multicenter retrospective study by the Spanish group GETH-TC.

Bone marrow transplantation·2026

Pleuroparenchymal fibroelastosis after allogeneic hematopoietic stem cell transplantation: Risk factors and longitudinal pulmonary function trajectories in a multicenter cohort.

Bone marrow transplantation·2026

Hyperacute Graft-Versus-Host Disease.

Bone marrow transplantation·2026

Itacitinib plus calcineurin inhibitor-based therapy for prophylaxis of graft-versus-host disease: GRAVITAS-119 results.

Bone marrow transplantation·2026

Music therapy and music-based support for autistic children: a neurodiversity-informed systematic review and meta-analysis.

Frontiers in psychiatry·2026

De-diagnosis and the problem of revisability in adult ADHD and autism.

Frontiers in sociology·2026

Validation of the Greek version of the Child perceptions questionnaire (CPQ-GR8-10) for assessing oral health-related quality of life in 8-10-year-old children: A psychometric evaluation.

Community dental health·2026

Risk factors for adolescent cannabis use following partial cannabis legalization in Germany: a cross-sectional study in secondary schools.

Substance abuse treatment, prevention, and policy·2026

Psychological and Neurodevelopmental Correlates of Extreme Demand Avoidance in a Clinical Sample, an Exploratory Study.

Autism research : official journal of the International Society for Autism Research·2026

Diagnosing adolescent borderline personality disorder in the inpatient setting.

Current problems in pediatric and adolescent health care·2026

Related Experiment Videos

Which factors influence the different outcome of therapy in adults and children with ALL?

Related Concept Videos

Blinatumomab vs historical standard therapy of adult relapsed/refractory acute lymphoblastic leukemia.

Detection of Minimal Residual Disease in Adult Acute Lymphoblastic Leukemia by Analysis of Gene Rearrangements and Correlation with Early Relapses.

Change in prognostic factors.

PF-114, a potent and selective inhibitor of native and mutated BCR/ABL is active against Philadelphia chromosome-positive (Ph+) leukemias harboring the T315I mutation.

Randomized comparison of prophylactic and minimal residual disease-triggered imatinib after allogeneic stem cell transplantation for BCR-ABL1-positive acute lymphoblastic leukemia.

Clinical and molecular characterization of early T-cell precursor leukemia: a high-risk subgroup in adult T-ALL with a high frequency of FLT3 mutations.

How could calreticulin-targeting therapies change the myelofibrosis transplant paradigm?

The prognostic impact of CEBPA mutation in acute myeloid leukemia patients undergoing allogeneic hematopoietic stem cell transplantation.

Bridging therapy in pediatric and AYA patients under 25 years with relapsed/refractory B-ALL undergoing anti-CD19 CAR-T therapy: a multicenter retrospective study by the Spanish group GETH-TC.

Pleuroparenchymal fibroelastosis after allogeneic hematopoietic stem cell transplantation: Risk factors and longitudinal pulmonary function trajectories in a multicenter cohort.

Hyperacute Graft-Versus-Host Disease.

Itacitinib plus calcineurin inhibitor-based therapy for prophylaxis of graft-versus-host disease: GRAVITAS-119 results.

Music therapy and music-based support for autistic children: a neurodiversity-informed systematic review and meta-analysis.

De-diagnosis and the problem of revisability in adult ADHD and autism.

Validation of the Greek version of the Child perceptions questionnaire (CPQ-GR8-10) for assessing oral health-related quality of life in 8-10-year-old children: A psychometric evaluation.

Risk factors for adolescent cannabis use following partial cannabis legalization in Germany: a cross-sectional study in secondary schools.

Psychological and Neurodevelopmental Correlates of Extreme Demand Avoidance in a Clinical Sample, an Exploratory Study.

Diagnosing adolescent borderline personality disorder in the inpatient setting.

Related Experiment Videos

Which factors influence the different outcome of therapy in adults and children with ALL?

Related Concept Videos

Related Articles